Inspire Medical Systems (INSP) Cash & Current Investments (2017 - 2026)

Inspire Medical Systems has reported Cash & Current Investments for 10 years, with the latest figure at $283.8 million in Q1 2026.

• Quarterly Cash & Current Investments fell 23.12% year-over-year to $283.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $283.8 million (down 23.12% YoY) and the FY2025 annual result came in at $308.3 million, down 30.81% from the prior year.
• Cash & Current Investments declined to $283.8 million in Q1 2026 per INSP's latest filing, from $308.3 million in the prior quarter.
• Over five years, Cash & Current Investments peaked at $467.1 million in Q2 2023 and troughed at $196.3 million in Q2 2022.
• A 5-year average of $379.1 million and a median of $427.5 million in 2022 frame the typical range for Cash & Current Investments.
• The sharpest annual moves came in 2023 and 2025: Cash & Current Investments surged 137.9% in 2023, then tumbled 31.56% in 2025.
• Over 5 years, Cash & Current Investments stood at $451.4 million in 2022, then climbed by 1.99% to $460.4 million in 2023, then dropped by 3.22% to $445.5 million in 2024, then slumped by 30.81% to $308.3 million in 2025, then dropped by 7.93% to $283.8 million in 2026.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $283.8 million, $308.3 million, and $322.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.